Unknown

Dataset Information

0

Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody.


ABSTRACT: The worldwide epidemic of novel coronavirus disease (COVID-19) has led to a strong demand for highly efficient immunobinding to achieve rapid and accurate on-site detection of SARS-CoV-2 antibodies. However, hour-scale time-consumption is usually required to ensure the adequacy of immunobinding on expensive large instruments in hospitals, and the common false negative or positive results often occur in rapid on-site immunoassay (e.g. immunochromatography). We solved this dilemma by presenting a reciprocating-flowing immunobinding (RF-immunobinding) strategy. RF-immunobinding enabled the antibodies in fluid contacting with the corresponding immobilized antigens on substrate repeatedly during continuous reciprocating-flowing, to achieve adequate immunobinding within 60 s. This strategy was further developed into an immunoassay method for the serological detection of 13 suspected COVID-19 patients. We obtained a 100% true negative and true positive rate and a limit of quantification (LOQ) of 4.14 pg/mL. Our strategy also can be a potential support for other areas related to immunorecognition, such as proteomics, immunopharmacology and immunohistochemistry.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC7834412 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody.

Liu Yiren Y   Tan Yayin Y   Fu Quanying Q   Lin Maoren M   He Jinxu J   He Suhua S   Yang Mei M   Chen Shoudeng S   Zhou Jianhua J  

Biosensors & bioelectronics 20201229


The worldwide epidemic of novel coronavirus disease (COVID-19) has led to a strong demand for highly efficient immunobinding to achieve rapid and accurate on-site detection of SARS-CoV-2 antibodies. However, hour-scale time-consumption is usually required to ensure the adequacy of immunobinding on expensive large instruments in hospitals, and the common false negative or positive results often occur in rapid on-site immunoassay (e.g. immunochromatography). We solved this dilemma by presenting a  ...[more]

Similar Datasets

| S-EPMC8340598 | biostudies-literature
| S-EPMC11853113 | biostudies-literature
| S-EPMC3188650 | biostudies-other
| S-EPMC6934823 | biostudies-literature
| S-EPMC9606137 | biostudies-literature
| S-EPMC9753264 | biostudies-literature
| S-EPMC8131687 | biostudies-literature
| S-EPMC4302060 | biostudies-other
| S-EPMC7295121 | biostudies-literature
| S-EPMC2967239 | biostudies-other